Pacific Biosciences of California Inc
NASDAQ:PACB
Pacific Biosciences of California Inc
Cash from Financing Activities
Pacific Biosciences of California Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Pacific Biosciences of California Inc
NASDAQ:PACB
|
Cash from Financing Activities
$108.9m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
0%
|
CAGR 10-Years
10%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash from Financing Activities
-$3.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
Danaher Corp
NYSE:DHR
|
Cash from Financing Activities
-$144m
|
CAGR 3-Years
67%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
17%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Cash from Financing Activities
-$859.6m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-13%
|
|
Agilent Technologies Inc
NYSE:A
|
Cash from Financing Activities
-$1.2B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-8%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash from Financing Activities
-$382m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
See Also
What is Pacific Biosciences of California Inc's Cash from Financing Activities?
Cash from Financing Activities
108.9m
USD
Based on the financial report for Dec 31, 2023, Pacific Biosciences of California Inc's Cash from Financing Activities amounts to 108.9m USD.
What is Pacific Biosciences of California Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
10%
Over the last year, the Cash from Financing Activities growth was 1 032%. The average annual Cash from Financing Activities growth rates for Pacific Biosciences of California Inc have been -24% over the past three years , and 10% over the past ten years .